Serological Classification of Xanthomonas Maltophilia (Pseudomonas Maltophilia) Based on Heat-stable O Antigens

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 1989 May 1

PMID 2473089

Citations 11

Authors

B Schable

D L RHODEN

R Hugh

R E Weaver

N Khardori

P B Smith

G P Bodey

R L Anderson

Affiliations

Soon will be listed here.

Abstract

Twenty-six serotypes of Xanthomonas maltophilia were defined by using 15 antisera described by Hugh and Ryschenkow (R. Hugh and E. Ryschenkow, J. Gen. Microbiol. 26:123-132, 1961) and 11 new antisera. The antisera were prepared by immunizing rabbits with bacterial strains heated at 100 degrees C for 2 h. Twelve antisera required adsorptions with cross-reacting heterologous immunizing strains. We tested 275 clinical and environmental strains of X. maltophilia with 26 antisera by the slide agglutination technique. A total of 259 (94.2%) strains were typeable, with 137 (49.8%) strains agglutinating in three antisera.

Citing Articles

Role of phosphoglucomutase of Stenotrophomonas maltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance.

McKay G, Woods D, MacDonald K, Poole K Infect Immun. 2003; 71(6):3068-75.

PMID: 12761084 PMC: 155759. DOI: 10.1128/IAI.71.6.3068-3075.2003.

Identification of Acinetobacter baumannii strains with monoclonal antibodies against the O antigens of their lipopolysaccharides.

Pantophlet R, Brade L, Brade H Clin Diagn Lab Immunol. 1999; 6(3):323-9.

PMID: 10225830 PMC: 103717. DOI: 10.1128/CDLI.6.3.323-329.1999.

Specificity of rabbit antisera against lipopolysaccharide of Acinetobacter.

Pantophlet R, Brade L, Dijkshoorn L, Brade H J Clin Microbiol. 1998; 36(5):1245-50.

PMID: 9574685 PMC: 104808. DOI: 10.1128/JCM.36.5.1245-1250.1998.

Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.

Denton M, Kerr K Clin Microbiol Rev. 1998; 11(1):57-80.

PMID: 9457429 PMC: 121376. DOI: 10.1128/CMR.11.1.57.

Epidemiological typing of Stenotrophomonas (Xanthomonas) maltophilia by PCR.

Chatelut M, Dournes J, Chabanon G, Marty N J Clin Microbiol. 1995; 33(4):912-4.

PMID: 7790459 PMC: 228066. DOI: 10.1128/jcm.33.4.912-914.1995.

References

Selander R, Caugant D, Ochman H, Musser J, Gilmour M, Whittam T . Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol. 1986; 51(5):873-84. PMC: 238981. DOI: 10.1128/aem.51.5.873-884.1986. View

Morrison Jr A, Hoffmann K, Wenzel R . Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital. J Clin Microbiol. 1986; 24(1):52-5. PMC: 268830. DOI: 10.1128/jcm.24.1.52-55.1986. View

Muder R, Yu V, Dummer J, Vinson C, Lumish R . Infections caused by Pseudomonas maltophilia. Expanding clinical spectrum. Arch Intern Med. 1987; 147(9):1672-4. View

Grimont F, Grimont P . Ribosomal ribonucleic acid gene restriction patterns as potential taxonomic tools. Ann Inst Pasteur Microbiol. 1986; 137B(2):165-75. DOI: 10.1016/s0769-2609(86)80105-3. View

Nord C, Wadstrom T, Wretlind B . Synergistic effect of combinations of sulfamethoxazole, trimethoprim, and colistin against Pseudomonas maltophilia and Pseudomonas cepacia. Antimicrob Agents Chemother. 1974; 6(4):521-3. PMC: 444683. DOI: 10.1128/AAC.6.4.521. View

Hugh R, RYSCHENKOW E . Pseudomonas maltophilia, an alcaligenes-like species. J Gen Microbiol. 1961; 26:123-32. DOI: 10.1099/00221287-26-1-123. View

Gilardi G . Pseudomonas maltophilia infections in man. Am J Clin Pathol. 1969; 51(1):58-61. DOI: 10.1093/ajcp/51.1.58. View

Gardner P, Griffin W, SWARTZ M, KUNZ L . Nonfermentative gram-negative bacilli of nosocomial interest. Am J Med. 1970; 48(6):735-49. DOI: 10.1016/s0002-9343(70)80009-2. View

Mikkelsen O . Serotyping of Pseudomonas aeruginosa. 2. Results of an O group classification. Acta Pathol Microbiol Scand B Microbiol Immunol. 1970; 78(2):163-75. View

10.

Gilardi G . Infrequently encountered Pseudomonas species causing infection in humans. Ann Intern Med. 1972; 77(2):211-5. DOI: 10.7326/0003-4819-77-2-211. View

11.

Moody M, YOUNG V, Kenton D . In vitro antibiotic susceptibility of pseudomonads other than Pseudomonas aeruginosa recovered from cancer patients. Antimicrob Agents Chemother. 1972; 2(5):344-9. PMC: 444318. DOI: 10.1128/AAC.2.5.344. View

12.

Wishart M, Riley T . Infection with Pseudomonas maltophilia hospital outbreak due to contaminated disinfectant. Med J Aust. 1976; 2(19):710-2. DOI: 10.5694/j.1326-5377.1976.tb128238.x. View

13.

Narasimhan S, Gopaul D, HATCH L . Pseudomonas maltophilia bacteremia associated with a prolapsed mitral valve. Am J Clin Pathol. 1977; 68(2):304-6. DOI: 10.1093/ajcp/68.2.304. View

14.

Holmes B, LAPAGE S, Easterling B . Distribution in clinical material and identification of Pseudomonas maltophilia. J Clin Pathol. 1979; 32(1):66-72. PMC: 1145570. DOI: 10.1136/jcp.32.1.66. View

15.

Felegie T, Yu V, Rumans L, Yee R . Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination. Antimicrob Agents Chemother. 1979; 16(6):833-7. PMC: 352962. DOI: 10.1128/AAC.16.6.833. View

16.

Yu V, Felegie T, Yee R, Pasculle A, Taylor F . Synergistic interaction in vitro with use of three antibiotics simultaneously against Pseudomonas maltophilia. J Infect Dis. 1980; 142(4):602-7. DOI: 10.1093/infdis/142.4.602. View

17.

Zuravleff J, Yu V . Infections caused by Pseudomonas maltophilia with emphasis on bacteremia: case reports and a review of the literature. Rev Infect Dis. 1982; 4(6):1236-46. DOI: 10.1093/clinids/4.6.1236. View

18.

Nagai T . Association of Pseudomonas maltophilia with malignant lesions. J Clin Microbiol. 1984; 20(5):1003-5. PMC: 271497. DOI: 10.1128/jcm.20.5.1003-1005.1984. View

19.

Schoch P, Cunha B . Pseudomonas maltophilia. Infect Control. 1987; 8(4):169-72. DOI: 10.1017/s019594170006584x. View